116 related articles for article (PubMed ID: 1139938)
21. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
Laurikka-Routti M; Haukkamaa M
Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
[TBL] [Abstract][Full Text] [Related]
22. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
23. Plasma levels of norethisterone in women with subcutaneous implants of norethisterone acetate.
Joshi JV; Naik VK; Joshi UM
Indian J Med Res; 1979 Oct; 70():625-31. PubMed ID: 541006
[TBL] [Abstract][Full Text] [Related]
24. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
[TBL] [Abstract][Full Text] [Related]
25. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
26. Norethisterone contraceptive microspheres.
Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
[TBL] [Abstract][Full Text] [Related]
27. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
28. Contraceptive pellet: small size but long life.
JAMA; 1977 Aug; 238(7):573. PubMed ID: 12259968
[TBL] [Abstract][Full Text] [Related]
29. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
30. Long-term contraception with a single implant of the progestin ST-1435.
Coutinho EM; da Silva AR; Carreira CM; Sivin I
Fertil Steril; 1981 Dec; 36(6):737-40. PubMed ID: 7308518
[TBL] [Abstract][Full Text] [Related]
31. Long-term contraception by steroid-releasing implants. IV. Biological effectiveness of norethindrone acetate (ENTA) implants in rats and rabbits.
Srivastava UK; Laumas KR
Contraception; 1975 Nov; 12(5):549-68. PubMed ID: 1192742
[No Abstract] [Full Text] [Related]
32. Menstrual blood loss with contraceptive subdermal levonorgestrel implants.
Nilsson CG; Holma P
Fertil Steril; 1981 Mar; 35(3):304-6. PubMed ID: 6781939
[TBL] [Abstract][Full Text] [Related]
33. Study of norethindrone in contraception.
Goldzieher JW; Moses LE; Ellis LT
JAMA; 1962 May; 180(5):359-61. PubMed ID: 12305165
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
Gupta GN; Saxena BB; Landesman R; Ledger WJ
Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
[TBL] [Abstract][Full Text] [Related]
35. Use of Anovlar in gynaecological disorders and contraception.
Shahani SM; Chiklikar A
J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
[TBL] [Abstract][Full Text] [Related]
36. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
[TBL] [Abstract][Full Text] [Related]
37. Metabolic and endocrine studies in women using norethindrone acetate implant.
Shahani SM; Kulkarni PP; Bhate PA; Patel KL
Contraception; 1979 Feb; 19(2):135-44. PubMed ID: 428230
[TBL] [Abstract][Full Text] [Related]
38. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
39. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
40. Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in women.
Croxatto HB; Díaz S; Quinteros E; Simoneti L; Kaplan E; Rencoret R; Leixelard P; Mártinez C
Contraception; 1975 Dec; 12(6):615-27. PubMed ID: 1204349
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]